Lazard Appoints Michele Colocci as Vice Chairman and Managing Director of Healthcare Investment Banking

Lazard, Inc. (NYSE: LAZ) has announced that Michele Colocci will join the firm on June 3, 2024, as Vice Chairman of Investment Banking and Managing Director of Healthcare. Based in London, Mr. Colocci’s appointment marks an acceleration in the growth of Lazard’s global healthcare franchise, led by David Gluckman, and strengthens its leading position in Europe, overseen by Jean-Louis Girodolle and Cyrus Kapadia.

Mr. Colocci is a globally recognized advisor, particularly in the healthcare sector, with extensive experience working with biopharma clients across EMEA, the US, and Japan. With over three decades of investment banking expertise, he most recently served as Managing Director and Chairman of M&A at Morgan Stanley. Previously, he held key leadership roles including Global Co-Head of Healthcare Investment Banking and Deputy Head of European Investment Banking at Morgan Stanley, as well as Global Co-Head of Healthcare Investment Banking at JPMorgan. Mr. Colocci started his career as a management consultant at Bain & Co. and holds degrees from Williams College and Harvard Business School.

Peter R. Orszag, Chief Executive Officer of Lazard, expressed confidence in Mr. Colocci’s appointment, highlighting his experience as a trusted advisor and emphasizing its value in advancing the expansion of Lazard’s European business and healthcare sector.

In his statement, Mr. Colocci expressed his excitement to join Lazard, emphasizing the firm’s commitment to providing clear, independent, and relevant advice to clients as they navigate risks and pursue growth.

Lazard’s leading EMEA business, representing nearly 40% of total financial advisory revenues as of March 31, 2024, underscores the strength of the team and the enduring relationships built over nearly two centuries. Lazard is also a prominent advisor in healthcare, with recent transactions including significant deals such as Vertex’s acquisition of Alpine Immune Sciences and Galderma’s IPO.

Founded in 1848, Lazard is a premier financial advisory and asset management firm, offering a wide range of services including mergers and acquisitions, capital markets, restructuring, and asset management solutions to institutions, corporations, governments, and individuals worldwide. For more information, visit

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter